bar

Award winners

The latest Credo Award and Five Pillar Leader Award winners were announced at Wednesday’s Clinical Enterprise Leadership Assembly at Langford Auditorium. Read More

New protocol takes the sting out of Children’s Hospital outpatient procedures

A patient comfort protocol is rendering minor procedures less painful and upsetting for younger outpatients of the Monroe Carell Jr. Children’s Hospital at Vanderbilt. Read More

2013 Academic Enterprise Faculty Awards

The 2013 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during Wednesday’s Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research. Award recipients were nominated by their faculty colleagues and chosen by the Academic Enterprise Faculty Awards Selection Committee. Read More

VICC hosts cancer researchers during annual retreat

The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center. Read More

New clinic links pediatric sarcoma treatment services

J. Carlton Smith noticed severe pain in his knee five years ago during a lacrosse tournament. Smith, then 13 years old, never imagined hearing the diagnosis doctors would give him: osteosarcoma, a cancer of the bone. Read More

Foundation lauds graduate student’s melanoma research

Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation. Read More

VUMC job fair for nurses April 10

Vanderbilt University Medical Center is sponsoring a job fair for nurses on Wednesday, April 10. Those who apply in advance can set up a specific interview time during the fair. Read More

New unit nursing structure stresses leadership, support

A new unit nursing leadership structure, rolling out first at the Monroe Carell Jr. Children’s Hospital at Vanderbilt, gives bedside nurses more support from their leaders. Read More

New faculty: Patrick Grohar brings a competitive spirit to childhood cancer research

Patrick Grohar came to Vanderbilt in January from the National Cancer Institute, bringing with him his passions and self-motivation for lab-based work. His research focuses on drug discovery in pediatric sarcomas, cancers that develop in bone and soft tissues. Read More

Combined drug therapy may delay melanoma progression

Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene. Read More

Myelosuppression unit set to move to new CCT space

New space on the 10th floor of the Critical Care Tower is allowing the myelosuppression unit to increase its number of available… Read More

Grant renewal boosts GI cancer research program

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI). Read More

Carmaker’s gift boosts childhood cancer research

Patrick Grohar, M.D., Ph.D., was awarded a $250,000 Hyundai Hope on Wheels grant last week for his research into potential drug therapies for Ewing sarcoma, a cancer of the bone. Read More

Stand Up to Cancer TV broadcast airs Sept. 7

Stand Up To Cancer (SU2C), the nonprofit organization that helps fund various Vanderbilt-Ingram Cancer Center (VICC) investigators, returns to prime time television… Read More

VICC debuts outpatient cancer clinic in Springfield

Vanderbilt-Ingram Cancer Center (VICC) has opened a new outpatient cancer clinic on the NorthCrest Medical Center campus in Springfield, Tenn., to bring high quality care to patients in Middle Tennessee and Southern Kentucky. Read More

Predators jump in to help fight childhood cancer

The Nashville Predators organization presented more than $151,000 to the Monroe Carell Jr. Children’s Hospital at Vanderbilt recently to fund cutting-edge cancer research. Read More

Study finds mutation in melanoma sensitive to drug

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read More

New cancer drug shows promise in early testing

An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma… Read More

Risk of secondary tumors from melanoma drug studied

A new study offers clues on why melanoma patients who are treated with oral drugs inhibiting the BRAF gene are at increased risk for developing secondary skin cancers. Read More

New melanoma drug nearly doubles survival in majority of patients

Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival. Read More